BIO-key International, Inc.

BIO-key International, Inc.'s next confirmed earnings release is scheduled for August 17, 2026.

As of June 30, 2026, BIO-key International, Inc. has 1.09M shares outstanding.

As of June 30, 2026, BIO-key International, Inc. maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.88, indicating elevated leverage, while an interest coverage ratio of -102.35 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. posted a negative return on equity (ROE) of -107.91, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -67.07, reflecting losses generated across the asset base. Inventory turnover of 3.61 indicates how many times BIO-key International, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. recorded 16,500.00 in income tax expense. The company reported a pretax loss of -6.02M and -6.04M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. generated 6.70M in revenue and converted that into -6.04M in net income, yielding earnings per share of -6.53. EBITDA reached -5.47M, while operating income came in at -3.29M.

As of June 30, 2026, BIO-key International, Inc. holds 1.38M in cash and equivalents against 861,852.00 in total debt, resulting in a net debt position of -667,180.00. Total book value stands at 4.33M, with working capital of 793,451.00 providing operational flexibility.

BIO-key International, Inc. produced -4.16M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, BIO-key International, Inc. posted a gross margin of 81.32, reflecting its pricing power and cost economics. The operating margin of -49.12 and net profit margin of -90.10 provide insight into operational efficiency.

BIO-key International, Inc.'s most recent stock split took place on April 30, 2026 with a 10:1 split ratio.